The Efficacy Of Intravenous Immunoglobulin Therapy In Treatment Induced Neuropathy Of Diabetes
Status:
Recruiting
Trial end date:
2021-09-01
Target enrollment:
Participant gender:
Summary
The goal of this pilot study is to obtain preliminary data on the magnitude of the treatment
effect of IVIG on the neuropathic pain and neuropathy severity associated with treatment
induced neuropathy (TIND).
The investigators hypothesize that immune globulin, administered intravenously (IVIG), will
reduce the pain associated with treatment induced neuropathy and reduce the neuropathy
severity.
Treatment induced neuropathy in diabetes, is an iatrogenic complications of diabetes. The
preliminary data will be used to power a larger treatment trial, and to aid the understanding
of the mitigating factors in the treatment response.